CSIMarket
 
Cv Sciences Inc   (CVSI)
Other Ticker:  
 
 
Price: $0.0351 $0.00 4.464%
Day's High: $0.0351 Week Perf: 13.96 %
Day's Low: $ 0.03 30 Day Perf: -5.14 %
Volume (M): 306 52 Wk High: $ 0.06
Volume (M$): $ 11 52 Wk Avg: $0.04
Open: $0.03 52 Wk Low: $0.03



 Market Capitalization (Millions $) 5
 Shares Outstanding (Millions) 155
 Employees -
 Revenues (TTM) (Millions $) 16
 Net Income (TTM) (Millions $) 2
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 0

Cv Sciences Inc
CV Sciences Inc is a biotechnology company that focuses on developing and commercializing novel therapeutics utilizing synthetic biology approaches. The company specializes in developing treatments for various diseases, including cancer, autoimmune disorders, and genetic disorders. CV Sciences Inc is known for its innovative research and development capabilities, aiming to improve the quality of life for patients through advanced biotechnological solutions.


   Company Address: 9530 Padgett Street, Suite 107 San Diego 92126 CA
   Company Phone Number: 290-2157   Stock Exchange / Ticker: CVSI
   CVSI is expected to report next financial results on March 29, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Cv Sciences Inc

CV Sciences Inc's Revenue Soars to $3.84 Million, Defying Industry Decline and Positioning for a Promising Future



CV Sciences Inc, a leading player in the Major Pharmaceutical Preparations industry, has managed to reach break-even on a modest revenue rise of 2.453% to $3.84 million in the financial interval closing September 30, 2023. While many companies in the same sector are struggling with declining revenue and dwindling business, CVSI stands out as a success story. This article aims to interpret the financial results and explore the potential impact on the company's future prospects.
Positive Revenue Growth:
In the third quarter of 2023, CV Sciences Inc experienced an impressive revenue increase of 2.453%. This notable achievement is even more remarkable when compared to the industry's average decline. The company's ability to successfully navigate the challenging economic landscape highlights its resilience and adaptability. This growth trajectory indicates a positive outlook for CVSI, suggesting that it may be positioned well to capitalize on future opportunities.

Cv Sciences Inc

Unmasking the Triumphs of Cv Sciences Inc: Revelations on Q2 Performance Amidst Unpredictable Challenges



The stock market is an ever-evolving domain where investors closely analyze the financial performance of companies to make informed investment decisions. In this article, we will delve into the financials of Cv Sciences Inc (CVSI) for the April to June 30, 2023 time-frame. We will analyze key figures and explore interesting facts that shed light on the company's performance and its potential future trajectory.
Earnings Per Share and Revenue:
During the specified time-frame, Cv Sciences Inc reported a loss of $-0.01 per share, showing improvement from the previous year's loss of $-0.03 per share. Additionally, the Income per Share decreased from $0.04 per share in the prior reporting period. This indicates a decline in profitability.

Cv Sciences Inc

Cv Sciences Inc Faces Heavy Revenue Decline of 6.724% in First Quarter of 2023 Earnings Season, Casting Doubt on Positive EPS Results

Cv Sciences Inc, a company engaged in Biotechnology & Pharmaceuticals, announced its first quarter earnings of 2023 with a reported EPS of $0.04 per share compared to last year's EPS of $-0.02. While this may seem like a positive turn of events, a closer look at the company's financial performance reveals a somewhat different story.
Firstly, the revenue of Cv Sciences Inc has declined by a staggering -6.724% to $4.15 million from the previous year, indicating a significant reduction in sales. Although there has been a sequential revenue increase of 7.211% from $3.87 million, it is still relatively small compared to the year-over-year decrease in revenue.






 

Cv Sciences Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com